Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Camurati-Engelmann Syndrome × Lomustine × 30 days × Clear all

Sponsor

Conditions

Glioblastoma 2 Neoplasms 1 Neoplasm Recurrence, Local 1 Medulloblastoma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡